KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Total Debt (2016 - 2025)

Boston Scientific (BSX) has disclosed Total Debt for 17 consecutive years, with $11.4 billion as the latest value for Q4 2025.

  • Quarterly Total Debt rose 6.42% to $11.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.4 billion through Dec 2025, up 6.42% year-over-year, with the annual reading at $11.4 billion for FY2025, 6.42% up from the prior year.
  • Total Debt hit $11.4 billion in Q4 2025 for Boston Scientific, down from $11.6 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $11.6 billion in Q3 2025 to a low of $8.6 billion in Q3 2022.
  • Historically, Total Debt has averaged $9.8 billion across 5 years, with a median of $9.1 billion in 2021.
  • Biggest five-year swings in Total Debt: soared 45375.0% in 2021 and later fell 5.51% in 2022.
  • Year by year, Total Debt stood at $9.1 billion in 2021, then fell by 1.43% to $8.9 billion in 2022, then grew by 1.87% to $9.1 billion in 2023, then grew by 18.06% to $10.7 billion in 2024, then increased by 6.42% to $11.4 billion in 2025.
  • Business Quant data shows Total Debt for BSX at $11.4 billion in Q4 2025, $11.6 billion in Q3 2025, and $11.6 billion in Q2 2025.